🔍

Health X Platform Limited (HEALTHX)

₹283.75 +0.09% last close, 16 Oct

📊 NSE: HEALTHX 🏢 Healthcare Service Provider 📢 Latest filing: 09 Oct 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Health X's revenue was ₹0.1 Cr (-20.0% year on year, -11.1% on the previous quarter), and net profit ₹-0.5 Cr (a bigger loss than a year earlier); the operating margin was -632.0%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹0.1	-20.0%	-11.1%
Operating profit	₹-0.5	loss widened	loss widened
Net profit	₹-0.5	loss widened	loss widened
EPS (₹)	-0.16	loss widened	loss widened
Operating margin	-632.0%	—	—

Full quarterly financials → Results calendar →

HEALTHX delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 75.63% of the HEALTHX shares traded on NSE were taken to delivery, against the stock's own 20-session average of 77.45%. That is close to its usual level. Turnover was only ₹9 lakh, so a handful of trades can move this figure. Volume was 0.4 times its average, well below normal.

75.63%Delivery, 16 Oct

77.45%Own 20-session average

0.4×Volume vs its average

₹283.75NSE close · +0.09%

Delivery in the last 5 sessions: 54.6% · 60.8% · 98.8% · 63.1% · 75.6%

Delivery across the market →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Health X Platform Submits Regulation 74(5) Demat Certificate for Q2 Ended September 30, 2026

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 09 Oct 2026, 04:18 PM

Health X Platform Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by Registrar and Share Transfer Agent MUFG Intime India Private Limited on October 3, 2026. It confirms that share certificates received for dematerialisation during the period were duly verified, cancelled, and substituted in the register of members within the mandated timeline. This is a routine quarterly compliance update with no material financial impact.

Compliance certificate filed under Regulation 74(5) for the quarter ended September 30, 2026
Certificate issued by RTA MUFG Intime India Private Limited dated October 3, 2026
Filing submitted to BSE (Scrip Code: 533259) and NSE on October 9, 2026

💡 No action is required as this is a standard quarterly administrative filing; track upcoming Q2 financial results for operational performance.

Health X Platform Shareholders Approve All 7 AGM Resolutions with Over 99.99% Majority

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 29 Sep 2026, 03:03 PM

Health X Platform Limited announced the voting results and scrutinizer's report for its 37th Annual General Meeting held on September 28, 2026. All seven resolutions were passed with over 99.99% votes in favor, with a total of 25,080,158 votes polled representing 78.84% of outstanding shares. Key approvals included the adoption of FY26 financial statements, reappointment of Mrs. Abha Mittal, re-appointment of Independent Director Mrs. Anjana Dikshit for a second 5-year term, and enabling resolutions for borrowing limits (Section 180(1)(c)), encumbrance of assets (Section 180(1)(a)), and inter-corporate loans/investments (Sections 185 and 186).

All 7 resolutions passed with over 99.99% voting approval by shareholders
Total votes polled stood at 25,080,158 shares out of 31,810,500 outstanding shares (78.84% turnout)
Promoter group polled 100% of their 23,560,627 shares in favor of all agenda items
Approved borrowing powers under Section 180(1)(c) and loans/investments under Sections 185 and 186
Independent Director Mrs. Anjana Dikshit re-appointed for a 5-year term from November 10, 2026 to November 9, 2031

💡 Track the company's upcoming Q2 FY27 financial results and operational updates to monitor whether the approved borrowing and investment powers are utilized for core business expansion.

Health X Platform Concludes 37th AGM; 104 Members Attend Amid Composite Scheme Progress

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Sep 2026, 07:43 PM

Health X Platform Limited concluded its 37th Annual General Meeting (AGM) on September 28, 2026, with 104 members attending via video conferencing. Key resolutions put to vote included adoption of FY26 financial statements, borrowing limits under Section 180(1)(c), and authorisations under Section 185 and Section 186. The Chairman also briefed shareholders on the ongoing Composite Scheme of Arrangement approved on June 10, 2026, which has been submitted for NOC to stock exchanges and RBI.

104 members attended the 37th AGM held via video conferencing on September 28, 2026
Special resolutions presented included borrowing limits and asset mortgaging under Section 180 of the Companies Act, 2013
Scheme of Arrangement approved by the Board on June 10, 2026 has been filed for NOC with Stock Exchanges and RBI
Re-appointment of Mrs. Anjana Dikshit as Independent Director for a 5-year term from November 10, 2026 to November 9, 2031 was tabled

💡 Track the upcoming disclosure of voting results within two working days and regulatory NOC updates regarding the Composite Scheme of Arrangement from NSE, BSE, RBI, and NCLT.

Health X Platform Dispatches 37th AGM Notice & KYC Reminder to Unregistered Shareholders

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 04 Sep 2026, 03:10 PM

Health X Platform Limited has dispatched notices to shareholders who do not have registered email addresses, providing weblinks to access the Annual Report for FY 2025-26. The 37th Annual General Meeting (AGM) of the company is scheduled to take place on September 28, 2026, at 3:00 PM IST via Video Conferencing. The communication also reminds physical share certificate holders to update KYC and nomination details with the RTA, MUFG Intime India Private Limited. This is a routine regulatory compliance filing under SEBI LODR Regulations.

37th Annual General Meeting scheduled for Monday, September 28, 2026, at 3:00 PM IST via Video Conferencing
Dispatched Annual Report FY 2025-26 access links to shareholders without registered email IDs under Reg 36(1)(b)
Reminded physical shareholders to complete mandatory KYC and nomination updation per SEBI Master Circular dated May 7, 2024
Registrar and Share Transfer Agent confirmed as MUFG Intime India Private Limited (formerly Link Intime India Private Limited)

💡 Shareholders holding physical shares should complete KYC and nomination updates to ensure receipt of future corporate benefits. Investors can track AGM proceedings and voting outcomes on September 28, 2026.

Health X Platform Submits FY26 Business Responsibility and Sustainability Report

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 04 Sep 2026, 02:15 PM

Health X Platform Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 under Regulation 34 of SEBI LODR Regulations. Wholesale pharmaceutical and OTC product trading accounts for 98.80% of the group's turnover. The consolidated entity employs 2,760 permanent staff, with female representation at 6.63% of employees and 50% of the Board. The report also highlights strategic realignment initiatives, including a proposed demerger of financial services activities and a subsidiary merger.

Wholesale trading of pharmaceutical and OTC products accounted for 98.80% of group turnover
Total permanent workforce stood at 2,760 employees across the consolidated entity
Female representation stood at 50.00% (3 out of 6) on the Board of Directors
Reported paid-up capital of Rs 3,181.05 Lakhs and net worth of Rs 270.86 crore
Employee turnover rate for FY 2025-26 was 43% compared to 35% in FY 2024-25

💡 Track progress on the proposed corporate restructuring, including the demerger of financial services and subsidiary merger mentioned in the disclosures.

Health X Platform Convenes 37th AGM on Sep 28, 2026; Seeks ₹500 Cr Borrowing Limit

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 04 Sep 2026, 12:45 PM

Health X Platform Limited has issued the notice for its 37th Annual General Meeting scheduled for September 28, 2026, via video conferencing. Key agenda items include standard adoption of FY26 financial statements and special resolutions seeking approval for borrowing limits up to Rs. 500 Crores under Section 180(1)(c) with associated asset charges. The company is also proposing the re-appointment of Independent Director Mrs. Anjana Dikshit for a second five-year term ending November 2031.

37th Annual General Meeting convened for September 28, 2026, at 3:00 PM IST via video conferencing.
Special resolution proposed to set an aggregate borrowing limit of up to Rs. 500 Crores under Section 180(1)(c).
Proposal to re-appoint Mrs. Anjana Dikshit as Independent Director for a second 5-year term from Nov 10, 2026, to Nov 9, 2031.
Director Mrs. Abha Mittal (holding 15,700 equity shares or 0.05% stake) retires by rotation and seeks re-appointment.

💡 Track the AGM voting outcome on September 28, 2026, particularly regarding the approval of the ₹500 Cr borrowing limit enabling resolution.

Health X Platform to Convene 37th Annual General Meeting on September 28, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 31 Aug 2026, 12:09 PM

Health X Platform Limited (formerly Sastasundar Ventures Limited) has scheduled its 37th Annual General Meeting (AGM) for Monday, September 28, 2026, at 3:00 PM IST. The meeting will be conducted virtually through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The Notice of the AGM along with the Annual Report for FY ended March 31, 2026, will be dispatched to shareholders in due course. This is a standard corporate compliance intimation under SEBI LODR Regulations.

37th Annual General Meeting scheduled for September 28, 2026, at 3:00 PM IST
AGM to be conducted via Video Conferencing / Other Audio Visual Means
Annual Report for the financial year ended March 31, 2026, to be circulated in due course

💡 Investors should review the upcoming Annual Report and AGM notice for detailed audited financial statements and key shareholder voting resolutions.

Health X Platform to Attend GIA Healthcare Day Investor Conference on August 31, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Aug 2026, 01:47 PM

Health X Platform Limited has scheduled an interaction with investors and analysts on Monday, August 31, 2026. The meeting will take place at the GIA Healthcare Day group conference in Mumbai from 2:00 PM to 3:30 PM IST. The company stated that only publicly available information will be shared with no unpublished price-sensitive information discussed.

Investor meeting scheduled for Monday, August 31, 2026
Time window set for 2:00 PM to 3:30 PM IST
Event: GIA Healthcare Day Group Conference at Jio World Convention Centre, Mumbai
Company confirmed only publicly available information will be shared

💡 Track post-meet disclosures or presentation uploads on stock exchanges to see if any new strategic roadmap details are shared.

Health X Platform Q1 FY27 Concall: EBITDA at ₹14.9 Cr, PAT ₹2 Cr as RetailerShakti Grows 48% YoY

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 17 Aug 2026, 07:05 PM

Health X Platform Limited submitted the transcript of its Q1 FY27 earnings conference call held on August 11, 2026. Management reported that RetailerShakti grew 48% YoY while SastaSundar grew 44% YoY, delivering a consolidated quarterly EBITDA of ₹14.9 crore and PAT of ₹2 crore. The company currently serves ~75,000 retail pharmacies (40,000 active in the last 30 days) with over 50,000 SKUs across Tier 2 and Tier 3 markets. Management indicated existing fulfillment infrastructure with planned extensions can support up to ₹3,000 crore in revenue with a working capital cycle of ~28 days.

RetailerShakti grew 48% YoY and SastaSundar grew 44% YoY during Q1 FY27
Q1 EBITDA stood at ₹14.9 crore and PAT reached ₹2 crore
Active transacting pharmacy network reached 40,000 in the last 30 days out of 75,000 registered pharmacies
Fulfillment capacity utilization is at 90%, with extensions capable of supporting up to ₹3,000 crore in revenue
Working capital cycle remains at approximately 28 days (~8% of revenue)

💡 Track the upcoming commercial rollout of the AI-based SaaS platform 'RetailAir' next quarter and SEBI approvals regarding the ongoing corporate scheme.

Health X Platform Limited Releases Q1 FY27 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 11 Aug 2026, 07:08 PM

Health X Platform Limited (formerly Sastasundar Ventures Limited) has released the audio recording of its Q1 FY27 earnings conference call held on August 11, 2026. During the call, senior management discussed the company's financial performance for the quarter ended June 30, 2026, and provided business updates. The recording includes an interactive question and answer session with analysts and investors. This is a standard procedural disclosure under SEBI (LODR) Regulations, 2015.

Earnings conference call conducted on August 11, 2026, at 4:00 PM IST
Discussion covered performance for the quarter ended June 30, 2026
Audio recording made available via a public weblink as per Regulation 30 of SEBI LODR
Interactive Q&A session held between senior management and institutional investors

💡 Investors should listen to the recording to understand management's commentary on Q1 FY27 performance and their outlook for the remainder of the fiscal year.

47% Y-o-Y Revenue Growth for HealthX as Gross Margins Expand to 7.9%

🟢 POSITIVE ⭐ 6/10

OTHER 📅 07 Aug 2026, 07:30 PM

HealthX Platform Limited (formerly Sastasundar Ventures) reported a strong 47% Y-o-Y revenue growth for the June 2026 quarter, with top-line momentum across all channels. Gross margins improved by 130 bps Y-o-Y to 7.9%, driven by better sourcing and a higher private-label mix. The company has successfully transitioned back to 100% ownership of the SastaSundar platform following the exit of Flipkart Health+ as an associate in FY25. While the company remains near break-even with an FY26 PAT of Rs -1.4 cr, it maintains a lean working capital cycle of 28 days.

Revenue grew 47% Y-o-Y and 16% Q-o-Q for the quarter ended June 2026.
Gross Margin expanded by 130 bps Y-o-Y to reach 7.9% in the current quarter.
Retailer Shakti platform achieved a 96% CAGR from FY20 to FY26, with sales reaching Rs 1,125 cr.
Net working capital cycle improved to 28 days, representing an 11% Y-o-Y reduction.
The company regained 100% operational control of SastaSundar after the Flipkart partnership ended in FY25.

💡 Investors should monitor the company's ability to convert high top-line growth into bottom-line profitability now that it has full operational control. Key metrics to watch include the continued expansion of gross margins and the absorption of fixed costs through operating leverage.

5-Year Re-appointment for Independent Director at Health X; Q1 Standalone Loss at Rs 51.43 Lakhs

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 07 Aug 2026, 05:43 PM

Health X Platform Limited (formerly Sastasundar Ventures) has re-appointed Mrs. Anjana Dikshit as an Independent Director for a second 5-year term starting November 10, 2026. The company's standalone financial results for Q1 FY27 show a revenue of Rs 8.00 lakhs, down from Rs 9.67 lakhs YoY. The standalone net loss for the quarter widened to Rs 51.43 lakhs compared to a loss of Rs 10.95 lakhs in the same period last year. A significant corporate restructuring via a Composite Scheme of Arrangement is currently pending regulatory approvals, with an effective date of April 1, 2026.

Re-appointment of Mrs. Anjana Dikshit as Independent Director for a 5-year term effective Nov 10, 2026.
Standalone revenue for Q1 FY27 reported at Rs 8.00 lakhs vs Rs 9.67 lakhs in Q1 FY26.
Standalone net loss for the quarter widened to Rs 51.43 lakhs from Rs 10.95 lakhs YoY.
Total standalone expenses for the quarter stood at Rs 60.72 lakhs.
Composite Scheme of Arrangement and Amalgamation pending with an appointed date of April 1, 2026.

💡 Investors should monitor the progress and regulatory approvals of the 'Composite Scheme of Arrangement' and the operational performance of the Genu Path Labs subsidiary.

Health X Platform Reports Q1 Net Loss of ₹51.43 Lakhs; Revenue Declines 17% YoY

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 07 Aug 2026, 05:35 PM

Health X Platform Limited (formerly Sastasundar Ventures) reported a standalone net loss of ₹51.43 lakhs for the quarter ended June 30, 2026, compared to a loss of ₹10.95 lakhs in the same period last year. Revenue from operations fell to ₹8.00 lakhs from ₹9.67 lakhs YoY, while total expenses surged to ₹60.72 lakhs. The company is currently undergoing a composite scheme of arrangement and amalgamation with Microsec Resources Private Limited, which is pending regulatory approval. Additionally, the board approved the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term.

Standalone net loss widened significantly to ₹51.43 lakhs in Q1 FY27 from ₹10.95 lakhs in Q1 FY26.
Revenue from operations decreased by 17.3% YoY to ₹8.00 lakhs.
Total expenses increased to ₹60.72 lakhs, primarily driven by 'Other Expenses' amounting to ₹50.30 lakhs.
Re-appointment of Mrs. Anjana Dikshit as Independent Director for a 5-year term starting November 10, 2026.
A composite scheme of arrangement with Microsec Resources Private Limited is pending, with an appointed date of April 01, 2026.

💡 Investors should monitor the regulatory approval timeline for the 'Composite Scheme of Arrangement' and the operational performance of the 'Healthcare Network' segment, which has been facing losses.

Aug 11, 2026: Health X Platform to Discuss Q1 FY27 Results in Earnings Call

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 05 Aug 2026, 05:39 PM

Health X Platform Limited (formerly Sastasundar Ventures) has scheduled its Q1 FY2026-27 earnings conference call for August 11, 2026, at 4:00 PM IST. The call will focus on the financial performance for the quarter ended June 30, 2026. This interaction is hosted by Go India Advisors and follows the company's recent rebranding. Management will provide business updates but will not share any unpublished price-sensitive information during the session.

Earnings call scheduled for August 11, 2026, at 16:00 IST.
Discussion focuses on the quarter ended June 30, 2026 (Q1 FY27).
Universal dial-in numbers provided are +91 22 6280 1557 and +91 22 7115 8383.
Contact information provided for host representatives at +91 9769364166.

💡 Monitor the release of Q1 FY27 financial results prior to the call on August 11, 2026, to assess the company's performance trajectory.

Health X Platform wins Rs 65.19 lakh tax dispute as CESTAT sets aside demand

🟢 POSITIVE ⭐ 3/10

LEGAL 📅 03 Aug 2026, 07:47 PM

Health X Platform Limited has received a favorable final order from CESTAT regarding a service tax dispute initiated in June 2014. The Commissioner of Service Tax, Kolkata, had previously demanded Rs 65.19 lakhs for alleged non-payment of service tax and cesses under the Finance Act, 1994. The tribunal has now set aside this demand and ruled that no penalties are imposable on the company. This resolution clears a decade-old legal hurdle with no material financial impact on the company.

CESTAT set aside a service tax demand totaling Rs 65,19,360
The litigation was originally initiated on 23-06-2014, spanning over 12 years
Final order pronounced on 30-07-2026 and received by the company on 03-08-2026
The tribunal ruled that no penalties are imposable on the company
Company confirms there is no material financial impact following this relief

💡 Investors should note the resolution of this legacy contingent liability; continue to monitor the Integrated Governance Report for other outstanding tax disputes.

View All HEALTHX Announcements on Live Market Tracking →